Insightful Science Acquires FCS Express™, Strengthening its Leadership Position as the Cloud for Scientific Discovery
“ The biggest opportunity to accelerate scientific innovation today is to significantly increase the ability to harness valuable insights from data generated in labs. By integrating FCS Express into our Cloud for Scientific Discovery, we help our customers better navigate the transformation to a data-driven culture and accelerate scientific advances that improve the lives of people everywhere.” “ Joining Insightful Science is important to help us achieve our mission to set new standards for the highest-quality and most trustworthy results from flow cytometry analysis,” said Dave Novo, Founder and CEO of De Novo Software. “ By deeply understanding our customers scientific workflows and data needs, we are uniquely positioned to continue to strengthen our platform by expanding and offering even more comprehensive solutions,” said Brett Ammundsen, CEO Bioinformatics at Insightful Science. “ With our integration, we take the lead in flow cytometry data analysis, and deliver real value for customers who rely on flow cytometry for facilitating multi-omics analysis to advance medicine in important areas such as immuno-oncology and infectious disease.” Insightful Science is a privately held portfolio company of Insight Partners, the leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies. In addition, De Novo Software has extensive experience creating custom data analysis solutions and integrating with large scale LIS and HIS systems.